Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

Bacil Pharma informs about quarterly statement on investor complaint

15 Jan 2016

Bacil Pharma has informed about quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Related Bacil Pharma Ltd. Links:

Bacil Pharma Share Price

6.65 0.00 (0.00%) Aug 02, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 785.85
Dr. Reddy's Lab 4783.30
Lupin 1145.20
Cadila Healthcare 584.80
Cipla 945.20
View more..
Sensex vs Bacil Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback